Baxter Announces Updates to Its Board of Directors
21 Agosto 2023 - 6:00PM
Business Wire
- Addition of Stephen H. Rusckowski complements and expands
current board expertise with deep healthcare industry and public
company board experience
- Michael Mahoney to resign after nearly eight years of board
service
Baxter International Inc. (NYSE:BAX), a global medtech leader,
today announced it has appointed Stephen (Steve) H. Rusckowski,
former chairman, president and chief executive officer of Quest
Diagnostics, Inc., to its board of directors. Effective today, Mr.
Rusckowski serves on Baxter’s Compensation and Human Capital, and
Quality, Compliance and Technology Committees. In addition, the
company has announced that Michael (Mike) Mahoney will be resigning
from the board effective Sept. 13, 2023, following nearly eight
years of service.
“We are pleased to welcome Steve to Baxter’s board,” said José
(Joe) E. Almeida, chairman, president and chief executive officer.
“His exemplary operational expertise, track record as a
transformational leader, and distinguished career as a strategic
operational executive will enhance our current board membership.
I’m confident Steve’s patient-centric approach will further advance
our Mission to Save and Sustain Lives.”
Added Almeida, “I also want to thank Mike for his many
contributions to the Baxter board over his eight-year tenure. His
extensive insight into the medical device industry and deep
leadership experience have helped guide Baxter’s ongoing
transformation, including our current strategic actions to drive
greater growth, innovation and performance.”
About Steve Rusckowski
Mr. Rusckowski most recently served as chairman, president and
chief executive officer of Quest Diagnostics, Inc. Prior to joining
Quest Diagnostics, he was CEO of Philips Healthcare, and earlier in
his career held roles of increasing responsibility at
Hewlett-Packard Company and Procter & Gamble Company. Mr.
Rusckowski currently serves as a director of Tenet Healthcare
Corporation and Qiagen Inc. and previously served as a member of
the boards of directors of Xerox Holdings Corporation, Covidien plc
and MedQuist, Inc. He earned a bachelor’s degree in mechanical
engineering from Worcester Polytechnic Institute and a Master of
Management Science from the Massachusetts Institute of Technology’s
Sloan School of Management.
About Baxter
Every day, millions of patients, caregivers and healthcare
providers rely on Baxter’s leading portfolio of diagnostic,
critical care, kidney care, nutrition, hospital and surgical
products used across patient homes, hospitals, physician offices
and other sites of care. For more than 90 years, we’ve been
operating at the critical intersection where innovations that save
and sustain lives meet the healthcare providers who make it happen.
With products, digital health solutions and therapies available in
more than 100 countries, Baxter’s employees worldwide are now
building upon the company’s rich heritage of medical breakthroughs
to advance the next generation of transformative healthcare
innovations. To learn more, visit www.baxter.com and follow us on
Twitter, LinkedIn and Facebook.
Baxter is a registered trademark of Baxter International
Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230821083923/en/
Media Contact Stacey Eisen, (224) 948-5353
media@baxter.com Investor Contact Clare Trachtman, (224)
948-3020
Baxter (NYSE:BAX)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Baxter (NYSE:BAX)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024